4.7 Article

A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer

期刊

MOLECULAR CANCER
卷 14, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/s12943-015-0473-3

关键词

Circulating microRNA; Gastric cancer; Diagnostic marker

资金

  1. Seed Funding Programme for Basic Research from Committee on Research and Conference Grants, The University of Hong Kong [201109159010]

向作者/读者索取更多资源

Background: Despite the declining incidence of gastric cancer, mortality rate remains high due to late presentation. We aimed to evaluate the sensitivity of miRNA as a diagnostic marker for gastric cancer in the circulation. Methods: Plasma samples from 3 independent groups comprise 123 gastric cancer patients and 111 healthy controls for miRNA profiling from microarray screening. Results: Microarray data showed that 25 miRNAs were upregulated in gastric cancer patients and 6 highly expressed miRNAs (miR-18a, miR-140-5p, miR-199a-3p, miR-627, miR-629 and miR-652) were selected for validation. In an independent validation set, levels of miR-627, miR-629 and miR-652 were significantly higher in gastric cancer patients than healthy controls (P < 0.0001). An algorithm with improved sensitivity and specificity as gastric cancer classifier was adopted and validated in another random set of 15 plasma samples. Results showed that combination of 3 miRNAs obtained the highest area under curve, with a cut-off at 0.373, with a sensitivity of 86.7 % and a specificity of 85.5 %. Conclusion: This study revealed a three-miRNA signature as a promising classifier for gastric cancer, and greatly enhances the feasibility of circulating miRNAs as non-invasive diagnostic marker for this disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Prospective clinical trial on the learning curve of high-intensity-focused ultrasound for the treatment of breast fibroadenoma

Michael Co, Clement Chen, Cassandra Lee, Stephanie Yu, Ava Kwong

Summary: The study found that treatment outcomes and treatment time for breast fibroadenoma significantly improved after approximately 40 HIFU procedures.

SURGERY TODAY (2022)

Article Genetics & Heredity

How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?

Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Chun Hang Au, Tsun-Leung Chan, Edmond Shiu Kwan

Summary: The evaluation of archival variants in BRCA1 and BRCA2 genetic testing can change management for some families due to increased or reduced risk. This indicates the need to address the lack of consensus management guidelines for VUS.

BMC MEDICAL GENOMICS (2022)

Correction Biochemistry & Molecular Biology

Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

Eileen O. Dareng, Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben, Muriel A. Adank, Simona Agata, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Gerasimos Aravantinos, Banu K. Arun, Annelie Augustinsson, Judith Balmana, Elisa V. Bandera, Rosa B. Barkardottir, Daniel Barrowdale, Matthias W. Beckmann, Alicia Beeghly-Fadiel, Javier Benitez, Marina Bermisheva, Marcus Q. Bernardini, Line Bjorge, Amanda Black, Natalia V. Bogdanova, Bernardo Bonanni, Ake Borg, James D. Brenton, Agnieszka Budzilowska, Ralf Butzow, Saundra S. Buys, Hui Cai, Maria A. Caligo, Ian Campbell, Rikki Cannioto, Hayley Cassingham, Jenny Chang-Claude, Stephen J. Chanock, Kexin Chen, Yoke-Eng Chiew, Wendy K. Chung, Kathleen B. M. Claes, Sarah Colonna, Linda S. Cook, Fergus J. Couch, Mary B. Daly, Fanny Dao, Eleanor Davies, Miguel de la Hoya, Robin de Putter, Joe Dennis, Allison DePersia, Peter Devilee, Orland Diez, Yuan Chun Ding, Jennifer A. Doherty, Susan M. Domchek, Thilo Dork, Andreas du Bois, Matthias Durst, Diana M. Eccles, Heather A. Eliassen, Christoph Engel, Gareth D. Evans, Peter A. Fasching, James M. Flanagan, Renee T. Fortner, Eva Machackova, Eitan Friedman, Patricia A. Ganz, Judy Garber, Francesca Gensini, Graham G. Giles, Gord Glendon, Andrew K. Godwin, Marc T. Goodman, Mark H. Greene, Jacek Gronwald, Eric Hahnen, Christopher A. Haiman, Niclas Hakansson, Ute Hamann, Thomas V. O. Hansen, Holly R. Harris, Mikael Hartman, Florian Heitz, Michelle A. T. Hildebrandt, Estrid Hogdall, Claus K. Hogdall, John L. Hopper, Ruea-Yea Huang, Chad Huff, Peter J. Hulick, David G. Huntsman, Evgeny N. Imyanitov, Claudine Isaacs, Anna Jakubowska, Paul A. James, Ramunas Janavicius, Allan Jensen, Oskar Th. Johannsson, Esther M. John, Michael E. Jones, Daehee Kang, Beth Y. Karlan, Anthony Karnezis, Linda E. Kelemen, Elza Khusnutdinova, Lambertus A. Kiemeney, Byoung-Gie Kim, Susanne K. Kjaer, Ian Komenaka, Jolanta Kupryjanczyk, Allison W. Kurian, Ava Kwong, Diether Lambrechts, Melissa C. Larson, Conxi Lazaro, Nhu D. Le, Goska Leslie, Jenny Lester, Fabienne Lesueur, Douglas A. Levine, Lian Li, Jingmei Li, Jennifer T. Loud, Karen H. Lu, Jan Lubinski, Phuong L. Mai, Siranoush Manoukian, Jeffrey R. Marks, Rayna Kim Matsuno, Keitaro Matsuo, Taymaa May, Lesley McGuffog, John R. McLaughlin, Iain A. McNeish, Noura Mebirouk, Usha Menon, Austin Miller, Roger L. Milne, Albina Minlikeeva, Francesmary Modugno, Marco Montagna, Kirsten B. Moysich, Elizabeth Munro, Katherine L. Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Joanne Ngeow Yuen Yie, Henriette Roed Nielsen, Finn C. Nielsen, Liene Nikitina-Zake, Kunle Odunsi, Kenneth Offit, Edith Olah, Siel Olbrecht, Olufunmilayo I. Olopade, Sara H. Olson, Hakan Olsson, Ana Osorio, Laura Papi, Sue K. Park, Michael T. Parsons, Harsha Pathak, Inge Sokilde Pedersen, Ana Peixoto, Tanja Pejovic, Pedro Perez-Segura, Jennifer B. Permuth, Beth Peshkin, Paolo Peterlongo, Anna Piskorz, Darya Prokofyeva, Paolo Radice, Johanna Rantala, Marjorie J. Riggan, Harvey A. Risch, Cristina Rodriguez-Antona, Eric Ross, Mary Anne Rossing, Ingo Runnebaum, Dale P. Sandler, Marta Santamarina, Penny Soucy, Rita K. Schmutzler, V. Wendy Setiawan, Kang Shan, Weiva Sieh, Jacques Simard, Christian F. Singer, Anna P. Sokolenko, Honglin Song, Melissa C. Southey, Helen Steed, Dominique Stoppa-Lyonnet, Rebecca Sutphen, Anthony J. Swerdlow, Yen Yen Tan, Manuel R. Teixeira, Soo Hwang Teo, Kathryn L. Terry, Mary Beth Terry, Mads Thomassen, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Darcy L. Thull, Marc Tischkowitz, Linda Titus, Amanda E. Toland, Diana Torres, Britton Trabert, Ruth Travis, Nadine Tung, Shelley S. Tworoger, Ellen Valen, Anne M. van Altena, Annemieke H. van der Hout, Els Van Nieuwenhuysen, Elizabeth J. van Rensburg, Ana Vega, Digna Velez Edwards, Robert A. Vierkant, Frances Wang, Barbara Wappenschmidt, Penelope M. Webb, Clarice R. Weinberg, Jeffrey N. Weitzel, Nicolas Wentzensen, Emily White, Alice S. Whittemore, Stacey J. Winham, Alicja Wolk, Yin-Ling Woo, Anna H. Wu, Li Yan, Drakoulis Yannoukakos, Katia M. Zavaglia, Wei Zheng, Argyrios Ziogas, Kristin K. Zorn, Zdenek Kleibl, Douglas Easton, Kate Lawrenson, Anna DeFazio, Thomas A. Sellers, Susan J. Ramus, Celeste L. Pearce, Alvaro N. Monteiro, Julie M. Cunningham, Ellen L. Goode, Joellen M. Schildkraut, Andrew Berchuck, Georgia Chenevix-Trench, Simon A. Gayther, Antonis C. Antoniou, Paul D. P. Pharoah

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Article Oncology

Relevance of the MHC region for breast cancer susceptibility in Asians

Peh Joo Ho, Alexis Jiaying Khng, Benita Kiat-Tee Tan, Ern Yu Tan, Su-Ming Tan, Veronique Kiak Mien Tan, Geok Hoon Lim, Kristan J. Aronson, Tsun L. Chan, Ji-Yeob Choi, Joe Dennis, Weang-Kee Ho, Ming-Feng Hou, Hidemi Ito, Motoki Iwasaki, Esther M. John, Daehee Kang, Sung-Won Kim, Allison W. Kurian, Ava Kwong, Artitaya Lophatananon, Keitaro Matsuo, Nur Aishah Mohd-Taib, Kenneth Muir, Rachel A. Murphy, Sue K. Park, Chen-Yang Shen, Xiao-Ou Shu, Soo Hwang Teo, Qin Wang, Taiki Yamaji, Wei Zheng, Manjeet K. Bolla, Alison M. Dunning, Douglas F. Easton, Paul D. P. Pharoah, Mikael Hartman, Jingmei Li

Summary: This study investigated the association between HLA genes and breast cancer susceptibility in Asian women. The results showed no significant association between any HLA allele and breast cancer risk in this population.

BREAST CANCER (2022)

Article Genetics & Heredity

Germline mutations in Chinese ovarian cancer with or without breast cancer

Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Chun Hang Au, Wing Pan Luk, Ling Hiu Fung, Tsun-Leung Chan, Karen Kar Loen Chan, Hextan Yuen Sheung Ngan, Edmond Shiu Kwan Ma

Summary: Identifying genetic mutations related to hereditary breast and ovarian cancer in Chinese patients has significant impacts on patient management and expanding screening options.

MOLECULAR GENETICS & GENOMIC MEDICINE (2022)

Meeting Abstract Oncology

KEYNOTE-355 Asian subset: Pembrolizumab plus chemotherapy vs placebo plus chemotherapy for triple-negative breast cancer

Toshimi Takano, Javier Cortes, David W. Cescon, Seock-Ah Im, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Valia Karantza, Hope S. Rugo, Peter Schmid

ANNALS OF ONCOLOGY (2022)

Article Oncology

Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study

Andreas Karakatsanis, Staffan Eriksson, Lida Pistiolis, Roger Olofsson Bagge, Gyula Nagy, Vivian Man, Ava Kwong, Fredrik Warnberg

Summary: This study demonstrates that marking the SLN with SPIO can avoid overtreatment and allow for accurate d-SLND in patients with DCIS. This is significant for the treatment of patients with DCIS.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Prospective Clinical Trial on Expanding Indications for Cryosurgery for Early Breast Cancers

Ava Kwong, Michael Co, Eisuke Fukuma

Summary: This study is a prospective single-arm clinical trial on cryosurgery for early breast cancers, evaluating the expanded criteria for tumors larger than 1.5 cm and non-luminal breast cancers. The results showed that residual cancer was found in 46.7% of patients, all of which were located at the periphery of the cryoablation zone. Careful pre-operative planning and intra-operative monitoring are crucial to ensure complete cryoablation.

CLINICAL BREAST CANCER (2023)

Article Medicine, General & Internal

Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors

Danielle Wing Lam Ng, Richard Fielding, Catherine Tsang, Carmen Ng, Joyce Chan, Amy Or, Izy Wing Man Kong, Julia Wei Chun Tang, Wylie Wai Yee Li, Amy Tien Yee Chang, Chi Choo Foo, Ava Kwong, Simon Siu-Man Ng, Dacita Suen, Miranda Chan, Oi-Kwan Chun, Karen Kar Loen Chan, Phyllis N. Butow, Wendy Wing Tak Lam

Summary: The purpose of this study is to evaluate the effectiveness of the Chinese version of the ConquerFear-HK intervention in improving fear of cancer recurrence. A randomized controlled trial will be conducted with 174 eligible Chinese cancer survivors who will be assigned to either the ConquerFear-HK or BasicCancerCare intervention. Various measures will be used to assess the intervention's effects and psychological impacts.

BMJ OPEN (2023)

Article Oncology

Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial

Vivian Man, Dacita Suen, Ava Kwong

Summary: The study compares the efficacy of superparamagnetic iron oxide (SPIO)-guided and standard techniques for detecting sentinel lymph nodes (SLN) in early breast cancer. Multiple inferiority trials have shown that SPIO is not inferior to conventional techniques in detecting SLNs. The results indicate that single-tracer SPIO-guided SLNB is as effective as the dual technique (radioisotope and blue dye) and can safely replace the gold standard for SLN mapping in early breast cancer.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria

Ava Kwong, Cecilia Y. S. Ho, Wing-Pan Luk, Ling-Hiu Fung, Chun-Hang Au, Edmond S. K. Ma

Summary: A study in the Chinese population found that the updated NCCN guidelines for the testing of breast cancer susceptibility genes had a positive effect on the detection rate of germline mutations. However, there is a need to carefully consider the balance between resources and outcomes.

CANCERS (2023)

Article Oncology

Implementing a nurse-led screening clinic for symptom distress with community-based referral for cancer survivors: A feasibility study

Wendy Wing Tak Lam, Danielle W. L. Ng, Richard Fielding, Vivian Sin, Catherine Tsang, Wendy W. L. Chan, Chi Chung Foo, Ava Kwong, Karen K. L. Chan

Summary: This study evaluated the feasibility of a nurse-led symptom-screening program in routine oncology post-treatment outpatient clinics. The results showed that this program was acceptable and effective in reducing symptom distress, with a high acceptance rate for community-based psychosocial support services.

PSYCHO-ONCOLOGY (2023)

Article Oncology

Inhibition of EP2 receptor suppresses tumor growth and chemoresistance of gastric cancer

Vivian Yvonne Shin, Michelle Xin Liu, Jennifer Man-Ting Siu, Ava Kwong, Kent-Man Chu

Summary: Gastric cancer is a leading cause of cancer death worldwide. This study found that expressing of EP2 receptor is significantly elevated in gastric cancer, and inhibiting EP2 receptor can reduce tumor growth and induce apoptosis in gastric cancer cells. Knockdown of EP2 receptor or using an antagonist also increased the sensitivity of gastric cancer cells to chemotherapy. CAV1 was identified as a downstream target of EP2 receptor in gastric cancer.

AMERICAN JOURNAL OF CANCER RESEARCH (2022)

暂无数据